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Probing the chemical basis of binding activity in an SH3 domain 
by protein signature analysis 
Tom W Muir*, Philip E Bawson, Michael C Fitzgerald and Stephen BH Kent 
Background: Modifying the covalent structure of a protein is an effective 
empirical route to probing three-dimensional structure and biological function. 
Here we describe a combinatorial protein chemistry strategy for studying 
structure-activity relationships in proteins. Our approach (termed ‘protein 
signature analysis’) involves functional selection from an array of self-encoded 
protein analogs prepared by total synthesis, coupled to a simple chemical 
readout that unambiguously identifies the modified proteins in the resulting active 
and inactive populations. 
Results: Protein signature analysis was used to study the interaction of the 
amino-terminal SH3 domain from the cellular adaptor protein c-Crk with its 
cognate proline-rich peptide, C3G. Using a functional selection assay, the 
qualitative effects of scanning a series of synthetic analog units through the 
amino-acid sequence of the SH3 domain were evaluated. The analog units were 
designed to alter both amino-acid sidechains and the polypeptide backbone 
within the protein. These chemical studies revealed that the sidechain of Asp1 50 
in the SH3 domain is essential for ligand binding and that changes in the 
structure of the polypeptide backbone can also result in loss of binding activity. 
Conclusions: These chemical studies have provided new insight into how 
ligand binding is related to the covalent structure of the SH3 domain. Protein 
signature analysis is a powerful and conceptually novel way of studying the 
molecular and chemical basis of protein function; it combines the advantages of 
systematic modification of a protein’s chemical structure with the practical 
convenience of combinatorial synthesis. 
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Introduction 
Understanding how the chemical structure of a protein 
determines its functional properties is an important 
current challenge in biological research. Altering the 
covalent structure of a protein has proven to be an 
extremely effective way of exploring the molecular basis 
of biological function. Site-directed mutagenesis of 
recombinantly expressed proteins offers a powerful route 
to studying the individual contributions of each amino 
acid sidechain in a protein to the function of the molecule 
[ 11. Classical mutagenesis techniques are constrained, in a 
chemical sense, to the covalent structures and stereo- 
chemistry of natural (i.e., genetically encoded) amino-acid 
residues, and to the natural peptidic linkage between 
them. These restrictions have been loosened by the 
development of novel in vitra expression approaches, 
which allow a range of unnatural amino acids to be 
incorporated into cloned proteins [2,3]. Moreover, 
significant advances in synthetic chemistry have recently 
transformed our ability to make proteins of small to 
moderate size in a practical fashion by total synthesis 
[4-lo]. Total chemical synthesis allows systematic 
variation of all aspects of the covalent structure of a 
protein, including the polypeptide backbone itself and the 
stereochemistry of the chiral carbon centers. These 
features make chemical synthesis an important comple- 
ment to site-directed mutagenesis in the study of smaller 
proteins and protein domains. 
In many cases, the particular amino-acid residues involved 
in a protein’s function are simply not known. One solution 
to this problem has been to use more exhaustive 
mutagenesis strategies involving the systematic replace- 
ment of each amino acid in a sequence with another 
residue, such as alanine [11-141. These scanning 
mutagenesis approaches provide a functional profile across 
the region being modified. However, even scanning muta- 
genesis is constrained in a practical sense by the large 
amount of effort required to construct and analyze indiv- 
idual mutant proteins, regardless of whether chemical 
synthesis or recombinant expression is being used. 
The recent emergence of combinatorial approaches in 
protein molecular biology has provided an alternative 
route to exhaustive mutagenesis of a protein sequence. 
By combining random oligonucleotide synthesis with 
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protein expression in bacteria [15] or on phage [16], it is 
possible to rapidly generate large libraries of protein 
sequences. When used with appropriate screening 
procedures these combinatorial techniques have proven 
useful in addressing protein-folding questions [17,18]. 
Combinatorial approaches of this type are, however, also 
constrained to the 20 naturally occuring amino acids, and 
it is still necessary to individually identify selected 
proteins following the screening assay. Furthermore, as 
only a tiny fraction of the total number of proteins 
generated can be fully characterized, it is very difficult to 
obtain functional profiles over a protein sequence using 
these techniques. 
We have recently developed a new technique for 
exploring the chemical basis of peptide and protein 
function (P.E.D., M.C.F., T.W.M. & S.B.H.K., sub- 
mitted). The principle of ‘protein signature analysis’ is 
illustrated in Figure 1. First, total chemical synthesis is 
used to prepare an array of self-encoded proteins in which 
an analog unit is systematically placed throughout a 
region of interest in the polypeptide chain, such that each 
member of the array contains a single copy of the analog 
unit at a unique and defined position. Second, the array 
of synthetic proteins is subjected to selection based on a 
specific functional property; this results in division of the 
original mixture into a positive (functional) pool and a 
negative (non-functional) pool. In the third and final step, 
the identities of the protein-analog molecules and the 
position of the analog unit within each protein are 
Figure 1 
simultaneously determined using a chemical readout 
system expressly built into the molecule for that purpose. 
The resulting decoded patterns form a signature relating 
the changes in chemical structure of the molecule to 
effects on protein function. 
The protein signature analysis technique combines the 
almost unlimited versatility of chemical synthesis for 
systematic modification of a protein’s covalent structure 
with the practical convenience that accompanies combin- 
atorial methods. An important feature of the protein 
signature analysis approach is that it permits the 
synthesis, selection and readout of defined mixtures of 
protein analogs. This property should be contrasted with 
other combinatorial techniques used to probe protein 
structure-function relationships, for example phage 
display, where readout of selected clones is carried out on 
an individual basis. The protein signature analysis 
principle is completely new to protein science, although a 
conceptually similar strategy has been devised for 
studying nucleic acids [ 19-2’4. 
Results and discussion 
Protein signature analysis of an SH3 domain 
In the form shown in Figure 1, protein signature analysis is 
a particularly useful way of looking at the chemical basis of 
ligand-binding activity in proteins. As an example of this, 
we have applied protein signature analysis to one of the Src 
homology 3 (SH3) binding domains commonly found in 
proteins involved in intracellular signal transduction. 
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The principle of protein signature analysis. 
Step 1: total chemical synthesis is used to 
generate an array of protein molecules 
derived from a single amino-acid sequence. 
An analog chemical structure (represented 
by the red and blue rectangles) is 
systematically incorporated at defined 
positions in the polypeptide chain. Step 2: 
the array of protein analogs is subjected to 
functional selection, resulting in separation 
into two populations: active and inactive. 
Step 3: the composition of each pool of 
analogs is then determined in a single step 
using a chemical readout system expressly 
built into the molecule for that purpose. This 
provides a signature relating the effects on 
function to substitution of the analog 
structure throughout the region of interest in 
the protein molecule. 
I 
‘Signatures/ 
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SH3 domains are small protein modules: polypeptide 
chains of about 60 amino acid residues that fold to form a 
unique three-dimensional structure, even outside the 
context of the longer polypeptide chain of the parent 
protein. It is now well established that SW3 domains 
mediate protein-protein interactions through the recog- 
nition of short proline-rich sequences [23]. The high- 
resolution structures of several SH3 domains have been 
determined by NMR spectroscopy and X-ray crystall- 
ography, both in the presence and absence of bound 
ligand [24]. Such studies have described the folded 
structure of the SH3 domain, and defined many of the 
structural criteria governing the specific recognition of 
proline-rich ligands by rhe protein domain [ZSJ. 
Our goal was to investigate the chemical basis of the 
interaction between the amino-terminal SH3 domain from 
the cellular adaptor protein c-Crk (residues 134-191 of the 
murine sequence) and its target ligand, a proline-rich 
peptide from the guanine nucleotide exchange protein 
C3G [26]. We wanted to change the chemical structure of 
the SH3 polypepride chain and observe how this affected 
the functional properties of the domain. 
Folded globular proteins found in nature are very robust, 
often retaining the native fold of the polypeptide chain as 
closely as possible, even in the face of extensive changes 
in the amino-acid sequence [l&27]. For this reason, we 
decided to introduce a dramatic perturbation in the 
chemical structure of the protein molecule: deletion of the 
sidechains of two adjacent amino acids in concert with the 
introduction of an extra backbone methylene. A thioester 
bond was also introduced to facilitate the identification of 
protein analogs (see beiow). The resulting Gly-[C~S]-~~a 
dipeptide analog unit can be compared with a native 
dipeptide sequence (see Fig. Za). 
Synthesis of an array of SH3 analogs 
We initially focused on a sequence of 20 amino acids near 
the middle of the SH3 polypeptide chain, c-Crk(146-165). 
As a first step an array of 19 protein analogs was 
chemically synthesized by placing the Gly-[COS]-gala 
dipeptide unit at each possible dipeptide position within 
the ZO-amino acid stretch. In this synthesis, we used the 
modified stepwise solid-phase peptide synthesis (SPPS) 
approach described in detail elsewhere (P.E.D., M.C.E, 
T.W.M. & S.B.H.K., submitted). This method made it 
possible to prepare all members of this array of analogs 
simultaneously in the course of a single synthesis (see Fig. 
3). This modified split-resin procedure ensured that each 
individual polypeptide chain in the final product mixture 
contained only one analog unit at a single defined 
position. Stepwise synthesis of the full-length 58-residue 
SH3 domain polypeptide, with the introduction of a 
chemical perturbation at 19 defined positions of the poly- 
peptide chain according to such a split-resin process, gave 
Figure 2 
(a) Native Dioeotide: 
-NH-CH-CO-NH-GH-CO- 
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Chemical structures of analog units. (a) Comparison of a native 
dipeptide unit (top) with the structures of the Gly-[COSI-Gly (middle) 
and Gly-[COST-PAla (bottom] analog units used in this study. (b) 
Selective chemical cleavage of the thioester bond within the analog 
unit can be carried out under mild conditions by treatment with 
hydro~lam;ne at neutral pH. The thioester bond is stable to the 
conditions normally used to study proteins. 
an array of analogs as a single product mixture containing 
the 19 desired molecular species. 
Functional selection by affinity chromatography 
The synthetic products were next subjected to functional 
selection. The amino-terminal SH3 domain from c-Crk 
specifically recognizes a lo-residue proline-rich sequence 
from the protein C3G [26]. A synthetic peptide contain- 
ing the proline-rich C3G sequence was covalently 
immobilized on commercially available derivatized 
agarose beads. In preliminary experiments, a synthetic 
SH3 domain corresponding to the wild-type sequence 
was found to bind specifically to the C3G peptide affinity 
column, but not to a control affinity column containing an 
immobilized non-specific peptide sequence, correspon- 
ding to leucine enkephalin. These procedures are 
described in detail elsewhere (P.E.D., T.W.M., M.C.E & 
S.B.H.K., submitted), and served to establish the validity 
of the affinity column assay. 
The effects of the dipeptide analog units on the binding 
properties of the SH3 domain were evaluated by passing 
the 19-member array of synthetic analogs of the 58-residue 
domain, as one pool, over the C3G peptide affinity 
column. The non~specificaIly bound protein analogs (the 
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Chemical synthesis of an array of protein analogs. A modified solid- growing peptide chain. The resin aliquot is then transferred to the 
phase peptide synthesis approach was developed that made it second reaction vessel and the remainder of the amino acids in the 
possible to prepare all members of the array of protein analogs sequence are coupled. Continual siphoning of resin aliquots from 
concurrently in the course of a single synthesis (P.E.D., M.C.F., vessel #l into vessel #2 (with analog attachment in between), results 
T.W.M., & S.B.H.K., submitted). This simple split-resin procedure in the generation of the complete protein array as a single product 
involves the use of two reaction vessels. At each stage of the mixture. Use of this split-resin procedure ensures that each compon- 
synthesis a small aliquot of the resin (with attached peptide) is ent of the array contains only a single copy of the analog at a unique 
removed from the first vessel, and the analog moiety attached to the and defined position. 
inactive pool) were first eluted from the column by 
washing with high-salt buffers. The remaining specifically 
bound protein analogs (the active pool) were then eluted 
by washing the affinity column with a buffer system 
containing 1 M NH,OH. This buffer disrupts the specific 
protein-ligand interactions by chemically cleaving the 
protein analogs (see later) resulting in their fragmentation 
and hence elution from the column. 
\ \ 
Readout of self-encoded’&rays of protein analogs 
The final step was to determine which protein analogs were 
present in each of the two pools. The identification of 
individual molecular species in a pool of closely related 
protein analogs is a formidable analytical challenge. One 
way to determine the molecular composition of such a 
mixture of protein analogs is to combine mass spectrometry 
with the synthetic chemistry approach, as schematically 
illustrated in Figure 4. 
The readout of all members of each pool of protein analogs 
was accomplished in a single step using a chemical 
decoding approach, similar in concept to that already 
described for use with nucleic acid libraries [19-Z]. A 
latent readout chemistry was built into each molecule in 
the course of the preparation of the protein array by total 
chemical synthesis. The analog unit contained a unique 
thioester chemical cleavage site (see Fig. Zb), which 
allowed us to chemoselectively ‘unzip’ the mixture of 
analog-containing polypeptide chains found in either the 
binding or non-binding pool. When examined by matrix- 
assisted laser desorption ionization (MALDI) mass 
spectrometry [28], the resulting sets of ‘decoded’ peptide 
fragments gave characteristic signatures that could be 
interpreted as follows. Each component of the mass 
spectrometric signature reflected the presence of the 
corresponding full-length polypeptide chain (containing the 
analog unit) in that pool of intact protein analogs (P.E.D., 
M.C.E, T.W.M. & S.B.H.K., submitted). Furthermore, the 
position of the analog unit in the original 5%residue c-Crk 
SH3 protein analog was defined by the position of the 
corresponding signal in the mass spectrometric signature, as 
schematically illustrated in Figure 4 [29,30]. 
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Fioure 4 
aa I -aa 2-aa 3-aa 4-aa 5-aa 6 COOH 
1 
Chemical cleavage 
ag-aaq-ag-sag 
----aq-ass-u 
MALDI readout 
N-terminal ladder ~-t~r~~~~l ladder 
M/Z 
Readout of self-encoded protein analog arrays. Building a latent 
chemical cleavage site into the analog unit (rectangle) means that each 
protein in the array will contain this chemical marker at a unique 
position in the polypeptide sequence. Chemical cleavage specifically 
at the analog unit gives rise to characteristic peptide fragments, each 
with a unique mass indicative of the position of the analog unit within 
the sequence of the original protein analog. Each protein analog in an 
array is thus self-encoded. Readout of these decoded peptide 
fragments can then be performed, in one operation, using MALDI mass 
spectrometry [291. 
Role of SH3 sidechains. 
The three components of protein signature analysis - 
synthesis, selection, and readout -will be described in 
detail in a series of model studies (P.E.D., M.C.F., T.W.M. 
& S.B.H.K., submitted). Here we have applied the 
integrated approach to an SH3 domain to elucidate the 
chemical basis of ligand binding. The results obtained 
from applying functional selection/chemical readout to the 
19-member array of protein analogs corresponding to the 
amino-terminal SH3 domain from c-Crk are shown in 
Figure 5. The mixture of synthetic protein analogs was 
passed over a C3G-peptide affinity column to assay for 
binding activity. The signature of the parent array of 
protein analogs (Fig. 5b) is compared with the signature of 
the pool that showed binding activity (Fig. SC). 
Eight (out of 19) members of the array of protein analogs 
bound to the C3G peptide. Perhaps of most interest was 
the pattern of binding and non-binding observed for 
Figure 5 
L i 
Protein signature analysis of a 20-residue region of the amino-terminal 
SH3 domain of murine c-Crk. (a) The highlighted amino acid sequence 
(residues 146-I 65) was substituted by the dipeptide analog Gly- 
[COS]$Ala, giving a 1 g-member array of synthetic analog proteins. 
(b) Signature of parent array after cleavage with neutral NH,OH and 
analysis by MALDI mass spectrometry. Only the family of amino- 
terminal fragments was observed in the spectrum. The carboxy-terminal 
fragments, although necessarily present, are not visible under the 
conditions used. Asterisks indicate terminated peptides arising from 
impurities in the commercial amino acids used. (c) Signature of the 
active (binding) pool eluted from the CSG-derived synthetic peptide 
affinity column. Eight analogs showed binding under these conditions; 
thus, the dipeptide sequences N146D147, D147E148, El 48E149, 
L151 P152, Ii 61 R162, R162D163, D163K164, and K164P165 could 
be replaced by the dipeptide analog without significant loss of activity. 
Dipeptide sequences in parentheses ((ED) and (DL)), indicate the Gly- 
[COSJ-pAla-containing protein analogs that do not show significant 
binding activity, as discussed in the text. (d) A region of the three- 
dimensional structure of the c-Crk-C3G complex [32], showing the 
three acidic residues within the RT loop of the SH3 domain interacting 
with Lys8 of the bound C3G peptide ligand. These interactions are 
believed to make an important contribution to binding, and to be 
critical in orienting the interaction of c-Crk with C3G. 
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proteins modified within the c-Crk( 146-152) region. This 
sequence of the SH3 protein corresponds to the so-called 
‘RT loop’, a region known to be involved in ligand 
binding throughout the SH3 domain family [24]. The 
sequence of this part of the c-Crk SH3 polypeptide is 
Asn-Asp-Glu-Glu-Asp-Leu-Pro. It is evident from the 
signature of the functional pool of SH3 analogs (Fig. 5c) 
that binding to the CSG-derived peptide ligand occurred 
even when the sidechains of the Asp147 or Glu149 
residues in the SH3 domain had been removed. Thus, 
interaction with the Asp147 or Glu149 sidechain carboxyls 
was not essential for binding (note that the effect of the 
replacement of these two residues on binding specificity 
cannot be inferred from this experiment). In contrast, 
removal of the sidechain of Asp150 by substitution with 
either the Gly or BAla portion of the dipeptide analog unit 
virtually eliminated binding; restoration of Asp150 
restored binding. It should be noted that Asp147 and 
Asp150 are both conserved in the viral form of the protein, 
v-Crk, whereas Glu149 is replaced with Gly [31]. 
These data are intriguing and offer experimental support 
for a difference in the roles of the three acidic sidechains 
in ligand binding, as previously suggested by the X-ray 
crystallographic data [32]. As shown in Figure 5d, all three 
of the sidechain carboxylate functionalities in residues 
Asp147, Glu149, and Asp150 of the c-Crk SH3 domain 
make specific interactions with the sidechain -aNH3+ of 
LysS in the l&and. From the protein signature analysis 
results presented here we can infer that the primary 
determinant of binding in this region of the SH3 molecule 
is the Asp150 sidechain carboxylate. 
The interaction of Asp147 and Glu149 sidechains with the 
peptide ligand may have a different role, perhaps affecting 
the specificity of binding by discriminating between Lys 
and Arg sidechains at this position [32]. The predominant 
role of Asp150 and the different roles of Asp147 and 
Glu149 were both suggested by the crystallography data. 
In the crystal structure, the -aNHs+ group of the lysine 
residue (in the Pro-rich peptide ligand) forms a hydrogen 
bond to an oxygen atom in the sidechain carboxylate of 
Aspl.50, using the preferred syn orientation of the oxygen 
lone electron pair as shown (Fig. 5d), whereas the 
hydrogen bonds to Asp147 and Glu149 are in the less 
favored anti orientation. The signature analysis data 
shown in Figure 5c are consistent with this crystal- 
lographic observation, because replacement of Asp150 
resulted in gross loss of binding activity, whereas 
replacement of Asp147 or Glu149 did not. 
Productive application of the signature analysis approach 
does not require knowledge of the three-dimensional 
structure of a protein domain. However, the three- 
dimensional structure can be used together with protein 
signature analysis to give additional insights into the 
chemical basis of protein function. In the example given 
here, the combination of signature analysis data with 
structural studies gave a more informative interpretation 
of the molecular basis of ligand binding than would have 
been possible with protein signature data alone. These 
results also show the potential of the protein signature 
analysis technique to illuminate the chemical reality of 
mechanisms suggested by the structural data. 
Role of SH3 backbone 
As shown in Figure 5, eight of the 19 protein analogs 
displayed binding activity, while 11 were inactive. We 
have discussed the implications of these observations for 
the roles of specific amino acid sidechains (above). How 
can we use these data to obtain information on the other 
factors that determine the chemical basis of binding by 
this SH3 domain? The non-functional members of the 
array of protein analogs could be inactive for any or all of 
the following reasons: deletion of amino acid sidechains, 
insertion of an extra methylene in the polypeptide back- 
bone, and deletion of the hydrogen-bonding ability of the 
central amide moiety in the analog structure. Information 
on which of these mechanisms is responsible for the loss 
of activity can be simply obtained by making another array 
containing alternative analog structures covering the 
region of interest in the SH3 domain. In this case, we 
made a second nine-membered array over the region 
cCrk(156-165) using -Gly-[COS]-Gly- as an analog unit in 
which the additional methylene of the original analog unit 
was not present (Fig. Za). 
The signature obtained after functional separation, based 
on binding to the proline-rich C3G peptide affinity column, 
and readout of this new nine-membered array of protein 
analogs is shown in Figure 6b. The signature in Figure 6c 
represents an expansion of the signature data shown in 
Figure 5c, but focussing on the region corresponding to 
replacement of residues 156-165 of the SH3 domain by the 
Gly-[COS]-BAla analog. Of the nine Gly-[COS]-BAla- 
containing SH3 analogs in this region, only four bound to 
the C3G peptide affinity column. The other five analogs 
did not bind under the conditions used. This pattern is 
identical to that observed for this region in a data set in 
which only these nine analogs were analyzed (P.E.D., 
T.W.M., M.C.E & S.B.H.K., submitted). 
In contrast, all nine (-Gly-[COS]-Gly-)-containing protein 
analogs exhibited appreciable binding activity in an 
identical assay (Fig. 6b). That so many of the protein 
analogs retained specific binding activity is remarkable, 
given the very substantial nature of the chemical changes 
made in the polypeptide chain. The data show that neither 
the pairwise deletion of sidechains nor deletion of the 
hydrogen bond in the central amide moiety of the analog 
structure was responsible for the lack of binding exhibited 
by the five inactive members of the original -Gly-[COS]- 
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Figure 6 
(W 
-Gly-[CoS]-Gly- ii I 
(d 
-Gly-[RX+PAla- 
(Binding pool! 
Iterative protein signature analysis applied to the amino-terminal SH3 
domain of murine c-Crk. (a) The amino acid sequence of the 58- 
residue polypeptide chain. Protein signature analysis was used to 
study how chemical variation of the central 1 O-residue region 
(highlighted residues 156-165) affected C3G peptide binding. Two 
rounds of signature analysis were performed, using different dipeptide 
analog units. (b) Round 1. Signature of the active (binding) pool 
obtained from the nine-membered array of Gly-LOS]-Gly-containing 
protein analogs. In contrast to the previous experiment, analysis of this 
signature reveals that all nine protein analogs were present in the 
binding pool. (c) Round 2. Signature of the active (binding) pool 
resulting from passing the parent array of Gly-[COS]$Ala-containing 
protein analogs over a CBG-derived synthetic peptide affinity column. 
The signature data shown represents an expansion of the larger 
signature shown in Figure 5c. Only four dipeptide sequences out of a 
total of nine (I1 61 RI 62; R162D163; Di 63K164; and K164P165) in 
this region could be replaced by Gly-[COSJ-SAla without significant 
loss of binding activity. 
PAla-containing array of protein analogs covering this 
region. Rather, it can be inferred from comparison of the 
two sets of data that the observed lack of binding activity 
was caused by insertion of the extra methylene in the 
polypeptide backbone by the original analog unit. Thus, it 
appears that the region defined by residues c-Crk(M-161) 
is less tolerant to backbone engineering than the region 
defined by residues c-Crk(161-165) (Fig. 7). The affinity 
binding assay used does not discriminate between a gross 
structural pertubation and a purely functional effect, since 
both could result in a loss of activity. However, none of the 
amino acids in the region being studied (residues 156-165) 
interact directly with the ligand, suggesting that the 
observed effects may be structural in origin. 
Implications 
These results clearly demonstrate the power of the 
protein signature analysis approach. These data could only 
have been obtained using a chemistry-driven technique of 
this type. Thus, precise dissection of the molecular basis 
of effects on protein function is possible through iterative 
application of the signature analysis method. Information 
obtained at each stage of studying a system can be used to 
guide systematic elucidation of the chemical basis of 
function for an entire molecule. At each cycle of experim- 
entation, the signatures are correlated with chemical 
changes at all sites being studied in the protein molecule. 
Such a process will inevitably reveal the chemical basis of 
the effects on activity. 
What contribution can the techniques described in this 
paper make to understanding how proteins work? 
Advances in total synthesis have opened the world of 
proteins, and in particular protein domains, to the tools of 
organic chemistry [33,34], allowing for variations of 
molecular structure not constrained by the genetic code 
(for example [35,36]). Total chemical synthesis thus 
provides an important complement to, and extension of, 
the powerful recombinant DNA-based techniques 
commonly used to study the molecular basis of protein 
function by variation of amino acid sidechains [1,11,15,16]. 
Using chemical synthesis it is possible to alter the covalent 
structure of a protein in ways simply not accessible to 
current molecular biology techniques, despite improve- 
ments of the recombinant DNA approach which have 
Figure 7 
Results from two rounds of protein signature analysis of the sequence 
comprising residues 156-l 65 superimposed on the crystal structure 
of the amino-terminal c-Crk SH3 domain complexed to the proline-rich 
C3G peptide [321. Indicated are those regions of the polypeptide 
chain observed to be either tolerant (green) or intolerant (red) of an 
extra backbone methylene group. 
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allowed for a variety of non-coded elements to be intro- 
duced into individual proteins at single sites [2,3]. 
However, the systematic application of both recombinant 
and chemical techniques has been tempered by the effort 
required to make, characterize, and assay individual analog 
proteins. What is needed is an approach that combines the 
versatility of chemistry with the ability to obtain, in a prac- 
tical fashion, a qualitative profile of the functional effects 
of structure variation throughout the protein molecule. 
Protein signature analysis is just such an approach. In 
essence it provides an empirical signature relating defined 
changes in the chemical structure of a protein to effects on 
its biological function. Synthesis of arrays of analog 
proteins allows the straightforward exploration of the 
entire sequence of a functional domain, or other region of 
interest in a protein molecule. Furthermore, modular 
chemical ligation [37,38] will allow the study of functional 
domains in the context of larger molecules, giving a global 
picture of the chemical basis of protein function. 
Significance 
Altering the covalent structure of a protein is a powerful 
way of elucidating the chemical basis of function. Here 
we describe a new technique, protein signature analysis, 
that allows the qualitative effect of performing a defined 
chemical modification to be evaluated simultaneously at 
all positions within a sequence. Protein signature 
analysis combines the versatility of chemistry for the 
systematic modification of a protein’s covalent structure 
with the practical convenience that accompanies 
combinatorial synthesis. This combinatorial protein 
chemistry approach has been applied to the amino- 
terminal SH3 domain from c-Crk. A total of 28 
chemically defined protein analogs were analyzed in 
only two protein signature analysis experiments. Using 
protein signature analysis, the effect on biological 
function of modifying both amino acid sidechains and 
the polypeptide backbone of the protein was determined. 
The latter of these, systematic backbone engineering, is 
unprecedented in the study of proteins. Protein 
signature analysis allows fundamental biological 
processes such as protein folding, binding and catalysis 
to come under the scrutiny of synthetic organic 
chemistry. Consequently, the technique provides a 
framework for the systematic application of chemistry 
to deciphering how proteins work, and thus comple- 
ments the analogous chemical approaches already 
available for the study of nucleic acids 1221. 
Materials and methods 
Synthesis of peptides 
With the exception of protein arrays (see below) all peptides were 
chemically synthesized according to optimized solid-phase methods 
[4], and purified by preparative reverse-phase high-pressure liquid 
chromatography (HPLC) using a Vydac C-18 column. In all cases, 
peptide composition and purity were confirmed by electrospray mass 
spectrometry and analytical reverse-phase HPLC. 
Synthesis of c-Crk SH3 protein arrays 
A detailed description of the split-resin procedure used will be published 
elsewhere (P.E.D., M.C.F., T.W.M. & S.B.H.K., submitted). Briefly, the 
technique involves the use of two reaction vessels with identical 
synthetic manipulations being carried out in each. Standard stepwise 
chain assembly [41 was initiated on resin in the first vessel (0.2 mmole 
scale); peptide-resin samples were repeatedly removed from the first 
vessel at each stage of the synthesis, and analog units were introduced 
into the polypeptide chain by coupling as preformed HOBt esters; after 
modification, the samples were transferred to the second vessel for 
completion of the chain assembly by standard stepwise chain assembly. 
The size of the samples was adjusted to yield approximately equal molar 
amounts of each protein analog in the array (dependent on the number of 
protein analogs in a given array). The dipeptide analogs Gly-[COSI-PAla 
and Gly-[COSI-Gly were prepared as previously described [39]. Upon 
completion of the synthesis, each parent protein array was characterized 
as follows: crude protein array (-1 mg) was dissolved in a cleavage 
buffer consisting of 1 M NH,OH, 20 mM NH,HCO,, pH 6.5 buffer 
(1 ml) and stirred for 15 min. The cleaved arrays were then exchanged 
into a 70 o/o CH,CN:30 % H,O, 0.1 e/o trifluoroacetic acid (TFA) solvent 
system (using a 1 ml C-l 8 desalting column) and immediately analyzed 
by MALDI mass spectrometry. 
Synthesis of peptide affinity columns 
The C3G peptide affinity column was prepared as follows. The peptide 
AC-CWBPPPALPPKKR-NH, (B = s-aminocaproic acid) was dissolved 
in 50 mM Tris, 5 mM EDTA, pH 8.0 (10 mg in 2 ml) and shaken with 
Sulfolink’M resin (Pierce) for 1 h. Unreacted iodoalkyl groups on the 
resin were then blocked by treatment with 50 mM cysteamine, 50 mM 
Tris, 5 mM EDTA, pH 8.0 buffer. The loading of the column was 
determined by UV to be -5 pmole ml-t. A similar procedure was used 
to attach the control peptide AC-CBYGGFL-NH, (YGGFL = leucine 
enkephalin) to the SulfolinkTM support. 
Affinity selection of protein arrays 
The crude protein array (1.5 mg) was dissolved in 20 mM Hepes, 
50 mM NaCl pH 7.3 buffer (600 ~1) and loaded onto a l-ml C3G 
peptide affinity column pre-equilibrated with the same buffer. After 
6-8 h the non-specifically bound material was eluted from the column 
by washing with 0.5 M NaCI, 0.1 M sodium phosphate, pH 7.0 buffer 
(6 x 1 ml). Eluted material (typically in the first and second wash) was 
immediately cleaved by dilution into 1 M NH,OH, 20 mM NH,HCOs, 
pH 6.5 buffer. Following further column washing with 1 M NaCI, 0.1 M 
sodium phosphate, pH 7.0 buffer, the specifically bound material 
(active pool) was chemically cleaved and simultaneously eluted from 
the affinity column by washing with 1 M NH,OH, 20 mM NH,HCO,, 
pH 6.5 buffer (4 x 1 ml). Eluted fractions were exchanged into a 70 % 
CH,CN:30 % H,O, 0.1 o/o TFA solvent system and immediately 
analyzed by MALDI mass spectrometry. 
MALDI analysis of peptide arrays 
All samples were prepared by adding 2 ~1 of the desalted column 
fraction to 5 p,I of a saturated solution of o-cyan0 cinnaminic acid in 
50 % acetonitrile in water, 0.1 e/o TFA. From this mixture, 2 ~1, 
containing -1-l 0 pmole of each pepide component, was added to a 
stainless steel probe tip and the solvent allowed to evaporate under 
ambient conditions. Mass spectra were recorded using a prototype 
laser desorption, linear time-of-flight mass spectrometer from Ciphergen 
Biosystems (Palo Alto, CA). Samples were desorbed/ionized using 
337 nm radiation output from a nitrogen laser (Laser Science, Inc., 
Newton MA). All spectra were acquired in the positive-ion mode and 
summed over 20-50 laser pulses. Time-to-mass conversion was 
accomplished by internal calibration using the [M+HI+ signals from the 
largest and smallest peptide components in each array. 
Research Paper Combinatorial synthesis of modified proteins Muir et al. 825 
Acknowledgements 
We thank Michael Youngquist and Steve Clark for helpful discussions 
regarding mass spectrometry data reduction. We thank Ciphergen 
Biosystems (Palo Alto, CA) for their generous gift of a MALDI mass 
spectrometer. Studies reported here were funded in part by NIH grants 
GM48870, HL31950, and GM48897. M.C.F. was an Amgen Fellow 
References -.-..--- 
1. 
2. 
3. 
4. 
5. 
6. 
7. 
8. 
9. 
10. 
11. 
12. 
13. 
14. 
15. 
16. 
1 7. 
18. 
19. 
20. 
21. 
22. 
Smith, M. (1994), Synthetic DNA and biology. (Nobel lecture). Angew. 
Chem. lnt. Ed. Engl. 33, 1214-I 221. 
Mendel, D., Ellman, J.A., Chang, Z., Veenstra, D.L., Kollman P.A. & 
Schultz, PG. (1992). Probing protein stability with unnatural amino 
acids. Science 256, 1798-l 802. 
Cornish, V.W., Mendel, D. & Schultz, P.G. (1995). Probing protein 
structure and function with an expanded genetic code. Anger Chem. 
Int. Ed. Engl. 34, 621-633. 
Schnolzer, M., Alewood, P., Jones, A., Alewood D. & Kent, S.B.H. 
(1992). ln situ neutralization in Boc-chemistry solid phase peptide 
synthesis: rapid, high yield assembly of difficult sequences. Int /. 
Pept. Protein Res. 40, 180-I 93. 
Schntilzer, M. & Kent, S.B.H. (1992). Constructing proteins by 
dovetailing unprotected synthetic peptides: backbone-engineered HIV 
protease. Science 256, 221-225. 
Gaertner, HF., Rose, K., Cotton, R., Timms, D., Camble R. & Offord, 
R.E. (1992). Construction of protein analogues by site-specific 
condensation of unprotected peptides. Bioconjugate Chem. 3, 
262-268. 
Dawson, P.E., Muir, T.W., Clark-Lewis I. & Kent, S.B.H. (1994). 
Synthesis of proteins by native chemical ligation. Science 266, 
776-779. 
Kemp, D.S. & Carey, R.I. (1993). Synthesis of a 39.peptide and a 
25peptide by thiol-capture ligations: observation of a 40.fold rate 
acceleration of the intramolecular O,N-acyl transfer reaction between 
peptide fragments bearing only cysteine protecting groups. J. Org. 
Chem. 58,2216-2222. 
Liu, C.-F. &Tam, J.P (1994). Peptide segment ligation strategy without 
use of protecting groups, Proc. Nat/. Acad. Sci. USA 91, 6584-6588. 
Nefzi, A., Sun X. & Mutter, M. (1995). Chemoselective ligation of 
multifunctional peptides to topological templates via thioether 
formation for TASP synthesis: Tetrahedron Left 36, 229-230. 
Cunningham, B.C. &Wells, J.A. (1989). High-resolution epitope 
mapping of hGH-receptor interactions by alanine-scanning 
mutagenesis. Science 244, 1081-I 085. 
Blaber, M., Baase, W.A., Gassner N. & Matthews, B.W. (1995). 
Alanine-scanning mutagenesis of the or-helix 115-I 23 of phage T4 
lysoyme: effect on structure, stability and binding of solvent. J. Mol. 
Biol. 246, 317-330. 
Tam, J.P., et al., & Ke, X.-H. (1989). Systematic approach to study the 
structure-activity of transforming growth factor 01. In Peptides: 
chemistry and biology [Proceedings of the 11 th American Peptide 
Symposium.] pp. 75-77, ESCOM, Leiden. 
Gibbs, C.S., et a/., & Leung, L.L.K. (1995). Conversion of thrombin 
into an anticoagulant by protein engineering. Nature 378, 413-416. 
Reidhaar-Olsen, J.F. & Sauer, R.T. (1988). Combinatorial cassette 
mutagenesis as a probe of the informational content of protein 
sequences. Science 241,53-57. 
Scott, J.K. & Smith, G.P. (1990). Searching for peptide ligands using 
an epitope ligand. Science 249, 386-390. 
Davidson, A.R.. Lumb K.L. & Sauer. R.T. (1995). Coooerative foldina 
proteins in random sequence libraries. A&t Sf~&t Bb/. 2, 856-862. 
Kamteker. S., Schiffer, J.M., Xiona, H.. Babik, J.M. & Hecht. M.H. 
(1993). Protein design by binary-patterning of polar and non-polar 
amino acids. Science 262, 1680-I 685. 
Hayashibara, K.C. & Verdine, G.L. (1991). Template-directed 
interference footprintina of protein-auanine contacts in DNA. J. Am. 
Chem.Soc.113',510&51'06. - 
Havashibara, K.C. & Verdine, G.L. (1992). Template-directed 
interference footprinting of cytosine contacts in a protein-DNA 
complex: potent interference of 5-aza-2’-deoxycytidine. Biochemistry 
31, 11265-I 1273. 
Mascarenas, J.L., Hayashibara, K.C. & Verdine, G.L. (1993). Template- 
directed interference footprinting of protein-thymidine contact. J. Am. 
Chem.Soc. 115,373-374. 
Min, C., Cushing, T.D. & Verdine, G.L. (1996). Template-directed 
interference footprinting of protein-adenine contacts. J. Am. Chem. 
Sot. 118,6116-6120. 
23. 
24. 
25. 
26. 
27. 
28. 
29. 
30. 
31. 
32. 
33. 
34, 
35. 
36. 
37. 
38. 
39. 
Pawson, T. & Schlessinger, J. (1993). SH2 and SH3 domains. Curr. 
Biol. 3, 434-442. 
Kuriyan, J. & Cowburn, D. (1993). Structures of SH2 and SH3 
domains. Curr. Opin. Strucf. Biol. 3, 828-837. 
Feng, S., Chen, J.K., Yu, H., Simon J.A. & Schreiber, S.A. (1994). Two 
binding orientations for peptides to the Src SH3 domain: 
development of a general model for SH3-ligand interactions. Science 
266,1241-1247. 
Knudsen, B.S., Feller SM. & Hanafusa, H. (1994). Four proline-rich 
sequences of the guanine-nucleotide exchange factor, C3G, bind with 
unique specificity to the first Src homology 3 domain of Crk. J. Viol. 
Chem. 269,32781-32787. 
Shortle, D. & Sondek, J. (1995). The emerging role of insertions and 
deletions in protein engineering. Curr. Opin. Biotechnol. 6, 387-393. 
Chait, B.T. & Kent, S.B.H. (1992). Weighing naked proteins: practical 
high accuracy mass measurement of peptides and proteins. Science 
257,1885-l 894. 
Chait, B.T., Wang, R., Beavis R.C. &Kent, S.B.H. (1993). Protein 
ladder sequencing. Science 262,89-92. 
Zhao, Y., Muir, T.W., Kent, S.B.H., Tischer, E., Scardina, J.M. & Chait, 
B.T. (1996). Mapping protein-protein interactions by affinity-directed 
mass spectrometry. Proc. Nat/. Acad. Sci. USA 93, 4020-4024. 
Mayer, B.J. & Hanafusa, H. (1993). Mutagenic analysis of the v-crk 
oncogene: requirement for the SH2 and SH3 domains and correlation 
between increased cellular phosphotyrosine and transformation. 1. 
Viol. 64, 3581-3589. 
Wu, X., et al., & Kuriyan, J. (1995). Structural basis for the specific 
interaction of lysine-containing proline-rich peptides with the 
N-terminal SH3 domain of c-Crk. Structure 3, 215-226. 
Muir, T.W. & Kent, S.B.H. (1993). The chemical synthesis of proteins, 
Cur. Opin. Biotechnol. 4, 420-427. 
Muir, T.W. (1995). A chemical approach to the construction of 
multimeric protein assemblies. Structure 3, 649-652. 
Baca, M., Alewood, P.F. & Kent, S.B.H. (1993). Structural engineering 
of the HIV-1 protease molecule with a p-turn mimic of fixed geometry. 
Prot, Sci. 2, 1085-I 091, 
Baca, M. & Kent, S.B.H. (1993). Catalytic contribution of flap- 
substrate hydrogen bonds in HIV-1 protease explored by chemical 
svnthesis. Proc. Nat/. Acad. Sci. USA 90, 11638-l 1642. 
Canne, L.E., Ferre-D’Amare, A.R., Burley, S.K. & Kent, S.B.H. (1995). 
Total chemical synthesis of a unique transcription factor-related 
protein: c-Myc-Max. J. Am. Chem. Sot. 117, 2998-3007. 
Baca, M., Muir, T.W., Schnblzer, M. &Kent, S.B.H. (1995). Chemical 
ligation of cysteine-containing peptides: synthesis of a 22.kDa 
tethered dimer HIV-I protease. J. Am. Chem. Sot. 117, 1881-I 887. 
Hojo, H. & Aimoto, S. (I 991). Polypeptide synthesis using the S-alkyl 
thioester of a partially protected peptide segment. Synthesis of the 
DNA-binding domain of c-Myb protein (142-l 93)-NH,. Bull. Chem. 
Sot. Jpn. 64, 11 l-l 1% 
